Follow
Alejandra Monserrat Rodriguez-Ramirez
Alejandra Monserrat Rodriguez-Ramirez
Instituto Nacional de Psiquiatría "Ramón de la Fuente Muñiz", Instituto Nacional de Ciencias Médicas
Verified email at incmnsz.mx
Title
Cited by
Cited by
Year
Insights into myelin dysfunction in schizophrenia and bipolar disorder
M Valdés-Tovar, AM Rodríguez-Ramírez, L Rodríguez-Cárdenas, ...
World Journal of Psychiatry 12 (2), 264, 2022
442022
CACNA1C Risk Variant and Mood Stabilizers Effects in the Prefrontal Cortical Thickness of Mexican Patients with Bipolar Disorder
AM Rodríguez-Ramírez, F Meza-Urzúa, V Cedillo-Ríos, C Becerra-Palars, ...
Neuropsychiatric Disease and Treatment, 1199-1206, 2020
72020
Neuropsychiatric genetics of psychosis in the Mexican population: a genome-wide association study protocol for schizophrenia, schizoaffective, and bipolar disorder patients and …
B Camarena, EG Atkinson, M Baker, C Becerra-Palars, LB Chibnik, ...
Complex Psychiatry 7 (3-4), 60-70, 2021
52021
Tratamiento farmacológico multidisciplinario para la atención integral del paciente con diabetes tipo 2
S Hernández-Jiménez, AC García-Ulloa, E González-Flores, ...
Revista de la Asociación Latinoamericana de Diabetes 12, 94-105, 2022
42022
Long-term effects of anxiety on the metabolic control of recently diagnosed type 2 diabetes patients: results from the CAIPaDi cohort study
AM Rodríguez-Ramírez, MT Alcántara-Garcés, S Hernández-Jiménez, ...
Neuropsychiatric Disease and Treatment, 197-207, 2023
32023
Comorbidity between recent diagnosis of type 2 diabetes and non-psychotic psychiatric disorders: metabolic characteristics and clinical correlates
MT Alcántara-Garcés, AM Rodríguez-Ramírez, AC García-Ulloa, ...
Neuropsychiatric Disease and Treatment 18, 1151, 2022
22022
Prefrontal cortical thickness and clinical characteristics of long-term treatment response to valproate in bipolar disorder
AM Rodríguez-Ramírez, V Cedillo-Ríos, C Becerra-Palars, F Meza-Urzua, ...
Psychiatry Research: Neuroimaging 317, 111382, 2021
22021
Association of BDNF risk variant and dorsolateral cortical thickness with long‐term treatment response to valproate in type I bipolar disorder: An exploratory study
AM Rodríguez‐Ramírez, V Cedillo‐Ríos, MA Sanabrais‐Jiménez, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 195 …, 2024
2024
Coping and risk perception during the COVID-19 pandemic in type 2 diabetes: Does it influence metabolic control?
MT Alcántara-Garcés, AM Rodríguez-Ramírez, AC García-Ulloa, ...
PLOS Global Public Health 4 (2), e0002793, 2024
2024
ASSOCIATION OF BDNF RISK VARIANT AND DORSOLATERAL CORTICAL THICKNESS WITH LONG-TERM TREATMENT RESPONSE TO VALPROATE IN TYPE I BIPOLAR DISORDER
AM Rodriguez-Ramirez, V Cedillo-Rios, C Becerra-Palars, ...
European Neuropsychopharmacology 63, e252-e253, 2022
2022
Abnormalities in White Matter and Response to Treatment with Lithium in Patients with Bipolar Disorder I
F Meza-Urzua, C Becerra Palars, V Cedillo-Rios, H Ortega-Ortiz, ...
BIPOLAR DISORDERS 20, 74-74, 2018
2018
Staging and clinical characteristics of bipolar patients with subcortical hyperintesities on magnetic resonance imaging
AM Rodriguez-Ramirez, CB Palars, V Cedillo-Rios, F Meza-Urzua, ...
BIPOLAR DISORDERS 20, 129-130, 2018
2018
The Use of Quetiapine for Comorbid Bipolar and Obsessive Compulsive Disorders
M Yoldi-Negrete, M Flores-Ramos, AM Rodríguez-Ramírez, CL Armando, ...
Current Psychopharmacology 4 (2), 103-111, 2015
2015
Agomelatine for Bipolar Depression: A Chronotherapeutic Agent?
M Yoldi-Negrete, C Becerra-Palars, A Carvajal-Lohr, ...
Current Psychopharmacology 4 (2), 84-95, 2015
2015
Neuropsychiatric genetics of psychosis in the Mexican population (NeuroMex): A GWAS protocol for schizophrenia, schizoaffective, and bipolar disorder patients and controls.
B Camarena, EG Atkinson, M Baker, C Becerra-Palars, LB Chibnik, ...
The system can't perform the operation now. Try again later.
Articles 1–15